We are live on ! Find out more
MFA

Mayflower Financial Advisors Portfolio holdings

AUM $1.16B
1-Year Est. Return 24.36%
This Fund
S&P 500
This Quarter Est. Return
-2.21%
1 Year Est. Return
+24.36%
3 Year Est. Return
+68.75%
5 Year Est. Return
+72.53%
10 Year Est. Return
AUM
$743M
AUM Growth
-$9.89M
Cap. Flow
+$115M
Cap. Flow %
15.47%
Top 10 Hldgs %
34.74%
Holding
378
New
25
Increased
197
Reduced
103
Closed
15

Sector Composition

Rank Sector Weight
1 Technology 10%
2 Consumer Discretionary 9.39%
3 Healthcare 8.3%
4 Consumer Staples 7.76%
5 Utilities 7.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PSK icon
326
State Street SPDR ICE Preferred Securities ETF
PSK
$685M
$208K 0.03%
5,320
-1,000
-16% -$40K
ADI icon
327
Analog Devices
ADI
$190B
$207K 0.03%
+1,253
New +$203K
BIIB icon
328
Biogen
BIIB
$30.7B
$206K 0.03%
+979
New +$213K
PH icon
329
Parker-Hannifin
PH
$135B
$206K 0.03%
727
+46
+7% +$13.9K
WFC icon
330
Wells Fargo
WFC
$264B
$206K 0.03%
4,245
+83
+2% +$4.44K
XEL icon
331
Xcel Energy
XEL
$48.8B
$204K 0.03%
+2,829
New +$194K
MSCI icon
332
MSCI
MSCI
$40.9B
$203K 0.03%
+404
New +$210K
EXR icon
333
Extra Space Storage
EXR
$31.6B
$201K 0.03%
980
+77
+9% +$15.3K
ELAN icon
334
Elanco Animal Health
ELAN
$11.1B
$200K 0.03%
7,680
+45
+0.6% +$1.2K
BRKL
335
DELISTED
Brookline Bancorp
BRKL
$183K 0.02%
11,567
SPH icon
336
Suburban Propane Partners
SPH
$1.18B
$161K 0.02%
10,000
SAND
337
DELISTED
Sandstorm Gold
SAND
$160K 0.02%
19,770
-2,500
-11% -$17.2K
SLQT icon
338
SelectQuote
SLQT
$121M
$153K 0.02%
54,911
-3,000
-5% -$14.5K
VAPO
339
DELISTED
Vapotherm, Inc. Common Stock
VAPO
$151K 0.02%
+1,356
New +$169K
NLY icon
340
Annaly Capital Management
NLY
$17.4B
$148K 0.02%
5,244
+811
+18% +$24.1K
INO icon
341
Inovio Pharmaceuticals
INO
$69M
$111K 0.01%
2,579
+33
+1% +$1.49K
REAL icon
342
The RealReal
REAL
$1.5B
$109K 0.01%
15,021
+21
+0.1% +$186
LILAK icon
343
Liberty Latin America Class C
LILAK
$1.64B
$97K 0.01%
11,167
ESGD icon
344
iShares ESG Aware MSCI EAFE ETF
ESGD
$12.3B
$77K 0.01%
13,241
+451
+4% +$34K
CRSP icon
345
CRISPR Therapeutics
CRSP
$5.17B
$50K 0.01%
+12,978
New +$815K
VKTX icon
346
Viking Therapeutics
VKTX
$4B
$40K 0.01%
13,485
CFRX
347
DELISTED
ContraFect Corporation
CFRX
$37K 0.01%
125
NGL icon
348
NGL Energy Partners
NGL
$2.11B
$24K ﹤0.01%
10,728
REVB icon
349
Revelation Biosciences
REVB
$4.46M
0
XFOR icon
350
X4 Pharmaceuticals
XFOR
$460M
$18K ﹤0.01%
333

Similar funds

Mayflower Financial Advisors's Q1 2022 Portfolio in Review

As of Q1 2022, Mayflower Financial Advisors held 378 positions worth $743M, down 1.3% from $753M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Mayflower Financial Advisors deployed $115M of net new capital in Q1 2022, opening 25 new positions and adding to 197 existing holdings. Its largest new stake was Schwab US TIPS ETF: 72,056 shares worth $2.19M.

By sector, the portfolio is most concentrated in Technology at 10% of assets, down from 10% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Vanguard Total Bond Market, an estimated $2.89M trimmed.

  • Mayflower Financial Advisors's largest Q1 2022 buy was Schwab US TIPS ETF: 72,056 shares worth $2.19M.
  • Mayflower Financial Advisors added most to Vertex Pharmaceuticals in Q1 2022, an estimated $92.7M increase.
  • Mayflower Financial Advisors's biggest Q1 2022 reduction was Vanguard Total Bond Market, cutting an estimated $2.89M.
  • Mayflower Financial Advisors fully exited State Street SPDR Nuveen ICE High Yield Municipal Bond ETF in Q1 2022, selling an estimated $395K.
  • Mayflower Financial Advisors's ten largest holdings make up 35% of its $743M portfolio in Q1 2022.
  • Mayflower Financial Advisors opened 25 new positions and closed 15 in Q1 2022.
  • Mayflower Financial Advisors's portfolio value fell 1.3% quarter-over-quarter to $743M.

Based on Mayflower Financial Advisors's 13F filing for Q1 2022, filed 21 Apr 2022.